Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
370 participants
OBSERVATIONAL
2014-12-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
NCT01461265
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases
NCT04167605
Cross Cultural Validation of the Italian Version of the Bt-DUX
NCT04074291
Evaluation of the Effectiveness of Prepectoral Breast Reconstruction
NCT05125991
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)
NCT06106282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed cancer of the breast, kidney, lung or prostate
* Bone metastases
* Estimated life expectancy of at least 6 months
* Fluent German speaking, reading and writing
* Informed written consent
Exclusion Criteria
* Participation in another study involving questionnaires
* Patients not able to comply with the assessments specified in the protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iOMEDICO AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norbert Marschner, MD
Role: PRINCIPAL_INVESTIGATOR
Outpatient Centre for Interdisciplinary Oncology and Haematology, D-Freiburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Multiple Sites All Over Germany
Multiple Locations, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marschner N, Wilke J, Reschke D, Kaiser F, Schmoor C, Grugel R, Boller E. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10). J Med Econ. 2018 Sep;21(9):920-929. doi: 10.1080/13696998.2018.1484750. Epub 2018 Jun 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IOM-268
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.